You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 2 clinical trial

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colitis, Ulcerative Trial (KSP-0243, Placebo)

Not yet recruiting
  • Colitis, Ulcerative
  • (no location specified)
Apr 14, 2023

Rheumatoid Arthritis Trial in Nashville (2-HOBA, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 26, 2023

Postpartum Depression Trial in Groningen, London (GH001)

Recruiting
  • Postpartum Depression
  • Groningen, Netherlands
  • +1 more
Apr 11, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 4, 2023

Bipolar II Disorder Trial in Dresden, Groningen (GH001)

Recruiting
  • Bipolar II Disorder
  • Dresden, Germany
  • +1 more
Apr 20, 2023

Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • TACE-HACI, plus atezolizumab-bevacizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 20, 2023

Concussion, Brain, Sleep Disorder Trial in Cincinnati (Brief Sleep Intervention)

Not yet recruiting
  • Concussion, Brain
  • Sleep Disorder
  • Brief Sleep Intervention
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Feb 11, 2023

Mild Alzheimer Trial in Seoul (PM012, PM012 Placebo, Donepezil)

Recruiting
  • Mild Alzheimer Disease
  • Seoul, Seongdon-gu, Korea, Republic of
    Mediforum
Apr 13, 2023

Disfigurement From Photographs of Neurofibromatosis Type 1

Completed
  • Neurofibromatosis 1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

    Not yet recruiting
    • AML, Adult
    • Pharmacoscopy
    • Clinical standard-of-care (physician's choice)
    • (no location specified)
    Nov 20, 2023

    Insomnia Disorder Trial in Tokyo (TS-142, Dose-matched Placebo to TS-142)

    Completed
    • Insomnia Disorder
    • TS-142
    • Dose-matched Placebo to TS-142
    • Tokyo, Japan
      Taisho Pharmaceutical Co., Ltd selected site
    Oct 4, 2022

    Osteoarthrosis Trial in Seoul (E1K 1,200 ?/joint, E1K 2,400 ?/joint, )

    Recruiting
    • Osteoarthrosis
    • E1K 1,200 ㎍/joint
    • +2 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jan 15, 2023

    Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)

    Not yet recruiting
    • Chikungunya Virus Infection
    • VLA1553 full dose
    • +2 more
    • (no location specified)
    Oct 24, 2023

    Atopic Dermatitis Trial in Bexley (Part 1 ADX-629 (Open-label))

    Not yet recruiting
    • Atopic Dermatitis
    • Part 1 ADX-629 (Open-label)
    • Bexley, Ohio
      Bexley Dermatology Research
    Feb 6, 2023

    Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • SKG0106
    • Katy, Texas
    • +1 more
    Aug 15, 2023

    Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas Trial in Boston (Imprime PGG, Rituximab)

    Completed
    Has Results
    • Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 20, 2022

    Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))

    Not yet recruiting
    • Stage II Melanoma
    • Relatlimab and nivolumab fixed dose combination (FDC)
    • Wollstonecraft, New South Wales, Australia
      Melanoma Institute Australia
    Oct 26, 2022

    Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

    Recruiting
    • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
    • dalpiciclib; fluvestrant; compound gossypol acetate tablets
    • Hangzhou, Zhejiang, China
      zhejiangCH
    Nov 9, 2023

    Severe Acute Respiratory Syndrome Coronavirus 2 Trial (COVAC-2, Saline Placebo)

    Not yet recruiting
    • Severe Acute Respiratory Syndrome Coronavirus 2
    • COVAC-2
    • Saline Placebo
    • (no location specified)
    Aug 5, 2022

    Alzheimer Trial in Houston (Interleukin-2, Placebo)

    Recruiting
    • Alzheimer Disease
    • Houston, Texas
      Houston Methodist Research Institute
    Oct 17, 2023

    Waldenström's Macroglobulinemia Trial (zanubrutinib,bendamustine,rituximab)

    Not yet recruiting
    • Waldenström's Macroglobulinemia
    • (no location specified)
    Aug 4, 2023

    Atopic Dermatitis Trial (BMX-010, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • (no location specified)
    Aug 4, 2022

    Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon

    Not yet recruiting
    • Chronic Hepatitis Delta
    • Peginterferon Lambda
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 25, 2023

    Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • (no location specified)
    Sep 29, 2022

    Menopause, Cognitive Change, Brain Disorder, Metabolic Trial (PhytoSERM, Placebo)

    Not yet recruiting
    • Menopause
    • +2 more
    • PhytoSERM
    • Placebo
    • (no location specified)
    Dec 22, 2022